SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Goldberg Sheldon L

(Last)

(First)

(Middle)

C/O CURAXIS PHARMACEUTICAL CORPORATION

4819 EMPEROR BLVD., SUITE 400

(Street)

DURHAM

27703

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
08/04/2010

3. Issuer Name and Ticker or Trading Symbol
CURAXIS PHARMACEUTICAL Corp [ ASCH ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	50,000	D⁽¹⁾
Common Stock	185,000	D⁽²⁾
Common Stock	100	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Purchase Warrant	11/15/2006	12/31/2011	Common Stock	60,000	$0.1	D⁽²⁾
Stock Option	04/18/2006⁽³⁾	04/18/2015	Common Stock	22,500	$8	D
Stock Option	04/18/2005⁽⁴⁾	04/18/2015	Common Stock	50,000	$8	D
Stock Option	05/09/2006⁽⁵⁾	05/09/2015	Common Stock	10,000	$10	D
Stock Option	01/01/2007⁽⁶⁾	05/18/2016	Common Stock	60,000	$6	D
Stock Option	01/01/2008⁽⁷⁾	02/05/2017	Common Stock	90,000	$1.51	D
Stock Option	09/08/2009⁽⁸⁾	09/08/2019	Common Stock	150,000	$0.2	D

Explanation of Responses:

1. Shares held by Shelberg LLC for which Sheldon L. Goldberg is the general partner.

2. As Trustee for the Sheldon L Goldberg Trust.

3. These Stock options vest as to 20% on April 18, 2006 and 20% on each April 18th thereafter based on continued service as a director through April 18, 2010.

4. 20% of the options vested immediately at the date of grant; 16% of the options vested on April 18, 2006 and 16% vested on each April 18 thereafter through April 18, 2010.

5. These stock options vest as to 20% on May 9, 2006 and 20% on each May 9th thereafter based on continued service as a director through May 9, 2010.

6. These Stock options vest as to 20% on January 1, 2007 and 20% on each January 1st thereafter based on continued service as a director through January 1, 2011.

7. These Stock options vest as to 20% on January 1, 2008 and 20% on each January 1st thereafter based on continued service as a director through January 1, 2012.

8. These stock options vested as to 100% of the shares on the grant date of September 8, 2009.

	/s/ Judith S. T. Geaslen	08/06/2010
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.